Key regions: Europe, Germany, United States, Brazil, Australia
The Other OTC Pharmaceuticals market in EU-27 is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the EU-27 region play a significant role in the development of the Other OTC Pharmaceuticals market. Consumers in this region are increasingly seeking self-care options and are more inclined to purchase over-the-counter medications for minor ailments. This preference is driven by the convenience, accessibility, and cost-effectiveness of OTC pharmaceuticals compared to prescription drugs. Additionally, the growing awareness of the benefits of preventive healthcare and the desire for immediate relief from common ailments further contribute to the demand for OTC pharmaceuticals.Trends in the market also contribute to the growth of the Other OTC Pharmaceuticals market in the EU-27 region. One notable trend is the increasing availability and variety of OTC products. Pharmaceutical companies are expanding their product portfolios to include a wide range of OTC medications, catering to the diverse needs of consumers. This trend is driven by the growing competition in the market and the need for companies to differentiate themselves by offering innovative and effective OTC solutions. Furthermore, the rise of e-commerce platforms has made it easier for consumers to access and purchase OTC pharmaceuticals, further fueling market growth.Local special circumstances in the EU-27 region also impact the development of the Other OTC Pharmaceuticals market. Each country within the EU-27 has its own regulatory framework and healthcare system, which can influence the availability and accessibility of OTC medications. Some countries may have more lenient regulations, allowing a wider range of OTC products to be sold, while others may have stricter regulations that limit the availability of certain medications. Additionally, cultural factors and healthcare practices specific to each country can also influence consumer preferences and purchasing behavior.Underlying macroeconomic factors also play a role in the growth of the Other OTC Pharmaceuticals market in the EU-27 region. Factors such as population growth, increasing disposable income, and improving healthcare infrastructure contribute to the demand for OTC pharmaceuticals. As the population in the EU-27 region continues to grow and age, the prevalence of minor ailments and chronic conditions increases, driving the need for OTC medications. Moreover, rising disposable incomes enable consumers to afford OTC pharmaceuticals, further boosting market growth. Additionally, the ongoing investments in healthcare infrastructure and the focus on preventive healthcare in the region create a favorable environment for the development of the Other OTC Pharmaceuticals market.In conclusion, the Other OTC Pharmaceuticals market in the EU-27 region is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for self-care options, the availability of a wide range of OTC products, country-specific regulations and healthcare practices, as well as population growth and improving healthcare infrastructure, all contribute to the growth of this market.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
